Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02244814PMID 1349751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration

  2004cited by this paper
• Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations.

  1991cited by this paper
• D1 antagonist in clinical trial.

  1990cited by this paper
• Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.

  1990cited by this paper
• Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing

  1990cited by this paper
• Dopamine D1 receptor antagonism in schizophrenia: is there reduced risk of extrapyramidal side-effects?

  1990cited by this paper
• A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor.

  1989cited by this paper
• Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.

  1989cited by this paper
• Therapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology.

  1988cited by this paper
• Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.

  1988cited by this paper
• EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.

  1988cited by this paper
• The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.

  1986cited by this paper
• Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection.

  1985cited by this paper
• Catalepsy induced by SCH 23390 in rats.

  1985cited by this paper
• SCH 23390 - the first selective dopamine D-1 antagonist.

  1983cited by this paper
• SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

  1983cited by this paper

• Activation of dopamine D2 receptor promotes pepsinogen secretion by suppressing somatostatin release from the mouse gastric mucosa.

  2022cites this paper
• Deciphering Spinal Endogenous Dopaminergic Mechanisms That Modulate Micturition Reflexes in Rats with Spinal Cord Injury

  2021influential citation
• Neural processing of the reward value of pleasant odorants.

  2021cites this paper
• Spinal Dopaminergic Mechanisms Regulating the Micturition Reflex in Male Rats with Complete Spinal Cord Injury

  2020cites this paper
• The late consolidation of an aversive memory is promoted by VTA dopamine release in the dorsal hippocampus

  2020cites this paper
• Context-Dependent and Context-Independent Effects of D1 Receptor Antagonism in the Basolateral and Central Amygdala during Cocaine Self-Administration

  2019cites this paper
• Dopamine D1-like receptors regulate agonistic components of pair bond maintenance behaviors in male titi monkeys (Callicebus cupreus).

  2019cites this paper
• Signatures neurales de la perception hédonique des odeurs chez la souris

  2018cites this paper
• Polypharmacological in Silico Bioactivity Profiling and Experimental Validation Uncovers Sedative-Hypnotic Effects of Approved and Experimental Drugs in Rat.

  2017cites this paper
• Role of Anterior Cingulate Cortex in Instrumental Learning: Blockade of Dopamine D1 Receptors Suppresses Overt but Not Covert Learning

  2017cites this paper
• An evaluation of cognitive deficits in a rat-model of Huntington's disease

  2016cites this paper
• Differential Effect of Orexin-1 and CRF-1 Antagonism on Stress Circuits: a fMRI Study in the Rat with the Pharmacological Stressor Yohimbine

  2013cites this paper
• The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations

  2012cites this paper
• Neutrophilic Airway Inflammation and Ovalbumin Antigen-Induced Response Attenuates Th17-Mediated Immune Dopamine D1-Like Receptor Antagonist

  2011cites this paper
• Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self‐administration

  2011cites this paper
• Probing brain function with pharmacological MRI

  2011cites this paper
• The Affinity of D2-Like Dopamine Receptor Antagonists Determines the Time to Maximal Effect on Cocaine Self-Administration

  2011cites this paper
• The Affinity of D 2-Like Dopamine Receptor Antagonists Determines the Time to Maximal Effect on Cocaine Self-Administration

  2011cites this paper
• Dopamine D1-Like Receptor Antagonist Attenuates Th17-Mediated Immune Response and Ovalbumin Antigen-Induced Neutrophilic Airway Inflammation

  2011cites this paper
• Effects of selective dopaminergic compounds on a delay-discounting task

  2011cites this paper
• Using the self-administration of apomorphine and cocaine to measure the pharmacodynamic potencies and pharmacokinetics of competitive dopamine receptor antagonists.

  2011cites this paper
• Antagonism at serotonin 5-HT2A receptors modulates functional activity of frontohippocampal circuit

  2010cites this paper
• Assessing animal models of impulsive behavior: Inter -model congruity, relationship to demand for cocaine, and effects of selective dopaminergic compounds

  2009cites this paper
• The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists

  2009cites this paper
• Determination of plasma and brain concentrations of SCH 39166 and their correlation to conditioned avoidance behavior in rats

  2005cites this paper
• A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393

  2005cites this paper
• Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.

  2004cites this paper
• Dopamine D1 and NMDA Receptors Mediate Potentiation of Basolateral Amygdala-Evoked Firing of Nucleus Accumbens Neurons

  2001cites this paper
• Hypothalamic CRH mRNA levels are differentially modulated by repeated 'binge' cocaine with or without D(1) dopamine receptor blockade.

  2001cites this paper
• Single restraint stress sensitizes acute chewing movements induced by haloperidol, but not if the 5-HT1A agonist 8-OH-DPAT is given prior to stress.

  1997cites this paper
• Dopamine D(1) antagonist SCH23390 attenuates self-administration of both cocaine and fentanyl in rats.

  1997cites this paper
• Modulation of basal ganglia neurotransmission by the classical antipsychotic fluphenazine is due in part to the blockade of dopamine D1-receptors.

  1997cites this paper
• Sensitive high-performance liquid chromatographic method for the determination of a benzonaphthazepine antipsychotic agent, SCH 39166, and its active metabolite, SCH 40853, in human plasma and its cross-validation with a gas chromatographic method.

  1996cites this paper
• Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate

  1995cites this paper
• Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements.

  1994cites this paper
• Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.

  1993cites this paper